Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Stephen G. Marcus
|
| gptkbp:developedBy |
novel therapeutics
|
| gptkbp:focusesOn |
oncology
neurodegenerative diseases inflammatory diseases |
| gptkbp:foundedYear |
2005
|
| gptkbp:headquartersLocation |
gptkb:Weston,_Florida,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cantex Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:website |
https://www.cantex.com/
|
| gptkbp:bfsParent |
gptkb:Neil_Flanzraich
|
| gptkbp:bfsLayer |
7
|